Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? (2021)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2020.635763
- Subjects: CANABINOIDES; TRANSTORNOS PSICÓTICOS; ESQUIZOFRENIA; TRANSTORNO AUTÍSTICO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 11, art. 635763, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
LOSS, Cássio Morais et al. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders?. Frontiers in Pharmacology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.635763. Acesso em: 08 out. 2024. -
APA
Loss, C. M., Teodoro, L., Rodrigues, G. D., Moreira, L. R., Peres, F. F., Zuardi, A. W., et al. (2021). Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.635763 -
NLM
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fphar.2020.635763 -
Vancouver
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA de S, Hallak JEC, Abilio VC. Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? [Internet]. Frontiers in Pharmacology. 2021 ; 11[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fphar.2020.635763 - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
Informações sobre o DOI: 10.3389/fphar.2020.635763 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003060263.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
